In hereditary cases, we observe shorter telomeres in cancer-affected MMR gene mutation carriers than in cancer-free carriers, suggesting either that the shortened telomeres are a result of the disease, or that shorter telomere length is an additional risk factor for LS patients, i.e. a risk modifier. Here, MRC1 is linked to Leigh syndrome.